No profile data available.
VolitionRx Limited (VNRX) is a healthcare company in the animal healthcare items industry, based in Henderson, United States, with about 57 full-time employees.
It reported revenue of $1.73 million for fiscal year 2025, up 40.0% from fiscal year 2024, and net income of -$23.36 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $398,657, down 2.0% from a year before. Its market capitalization was $6.35 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. Q Discover, a solution to profiling nucleosomes.
VolitionRx reported $1.73 million in revenue for fiscal year 2025, up 40.0% from $1.23 million in fiscal year 2024. In Q2 2026 revenue was $398,657.
$6.35 million as of October 9, 2026.
Listed companies of a similar size in the same industry (animal healthcare items) include ImmuCell Corporation (ICCC), Zhengye Biotechnology Holding Limited (ZYBT), Provectus Biopharmaceuticals, Inc. (PVCT).